CELLDEX THERAPEUTICS INC NEW

Ticker: CLDX CUSIP: 15117B202 Class: Common Stock

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023

Shares 106,057 Value ($000) $3,816 Avg Close $43.15 Range $33.83 - $48.40

Q4 2022

Shares 267,476 Value ($000) $11,921 Avg Close $35.70 Range $27.01 - $46.04

Q3 2022

Shares 317,476 Value ($000) $8,924 Avg Close $30.66 Range $21.65 - $38.52

Q2 2022

Shares 537,958 Value ($000) $14,504 Avg Close $29.04 Range $19.85 - $37.95

Q1 2022

Shares 537,958 Value ($000) $18,323 Avg Close $31.97 Range $26.47 - $39.84

Q4 2021

Shares 419,216 Value ($000) $16,198 Avg Close $43.58 Range $35.00 - $57.20

Q3 2021

Shares 270,431 Value ($000) $14,600 Avg Close $46.92 Range $28.30 - $56.17

Q2 2021

Shares 365,544 Value ($000) $12,224 Avg Close $27.45 Range $19.71 - $35.69

Q1 2021

Shares 596,290 Value ($000) $12,284 Avg Close $22.96 Range $15.37 - $30.17

Q4 2020

Shares 1,364,990 Value ($000) $23,915 Avg Close $18.00 Range $14.40 - $23.40

Q3 2020

Shares 1,469,730 Value ($000) $21,796 Avg Close $11.71 Range $9.59 - $16.19

Q2 2020

Shares 1,647,439 Value ($000) $21,417 Avg Close $4.43 Range $1.56 - $13.91

Period	Shares	Value ($000)	Average Close	Price Range
Q1 2023	106,057	$3,816	$43.15	$33.83 - $48.40
Q4 2022	267,476	$11,921	$35.70	$27.01 - $46.04
Q3 2022	317,476	$8,924	$30.66	$21.65 - $38.52
Q2 2022	537,958	$14,504	$29.04	$19.85 - $37.95
Q1 2022	537,958	$18,323	$31.97	$26.47 - $39.84
Q4 2021	419,216	$16,198	$43.58	$35.00 - $57.20
Q3 2021	270,431	$14,600	$46.92	$28.30 - $56.17
Q2 2021	365,544	$12,224	$27.45	$19.71 - $35.69
Q1 2021	596,290	$12,284	$22.96	$15.37 - $30.17
Q4 2020	1,364,990	$23,915	$18.00	$14.40 - $23.40
Q3 2020	1,469,730	$21,796	$11.71	$9.59 - $16.19
Q2 2020	1,647,439	$21,417	$4.43	$1.56 - $13.91